04:40:27 EDT Tue 28 Mar 2023
Enter Symbol
or Name

Login ID:

News for C:AWKN from 2022-03-29 to 2023-03-28 - 41 items News ReleasesIn The NewsOther CAUS
2023-03-02 15:32C:AWKNAwakn Life Sciences Corp0.39News ReleasePharmala Biotech to supply MDMA to Awakn
2023-02-28 13:01C:AWKNAwakn Life Sciences Corp0.36News ReleaseAwakn Life Sciences signs 4th licensing deal in N.A.
2023-02-21 10:42C:AWKNAwakn Life Sciences Corp0.46News ReleaseAwakn Life Sciences signs first European licensing deal
2023-02-14 12:52C:AWKNAwakn Life Sciences Corp0.465News ReleaseAwakn Life opens second ketamine clinic in Norway
2023-02-09 10:53C:AWKNAwakn Life Sciences Corp0.60News ReleaseAwakn begins MDMA FS with Catalent's Zydis ODT tech
2023-02-08 18:37C:AWKNAwakn Life Sciences Corp0.60News ReleaseAwakn acknowledges recent promotional activity
2023-02-07 10:19C:AWKNAwakn Life Sciences Corp0.53News ReleaseAwakn Life receives fast-track designation in U.K.
2023-01-24 10:46C:AWKNAwakn Life Sciences Corp0.33News ReleaseAwakn starts (S)-ketamine investigative study
2022-12-15 12:03C:AWKNAwakn Life Sciences Corp0.335News ReleaseAwakn talks revenue, omits Q3 2022 P&L in NR
2022-12-15 07:39C:AWKNAwakn Life Sciences Corp0.355SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-12-15 07:33C:AWKNAwakn Life Sciences Corp0.355SEDAR MD & ASEDAR MD & A
2022-12-13 11:45C:AWKNAwakn Life Sciences Corp0.35News ReleaseAwakn to conduct phase III trial at 7 NHS sites in U.K.
2022-12-01 12:24C:AWKNAwakn Life Sciences Corp0.42News ReleaseAwakn signs five-year lease for 2nd clinic in Norway
2022-11-23 10:53C:AWKNAwakn Life Sciences Corp0.34News ReleaseAwakn signs five-year lease for larger Oslo clinic
2022-11-17 12:19C:AWKNAwakn Life Sciences Corp0.39News ReleaseAwakn closes $1.86M second tranche of financing
2022-11-09 15:52C:AWKNAwakn Life Sciences CorpNews ReleaseAwakn Life Sciences signs 3rd licensing deal in N.A.
2022-10-25 12:45C:AWKNAwakn Life Sciences Corp0.33News ReleaseAwakn Life Sciences arranges $775,000 loan from TD Veen
2022-09-15 12:51C:AWKNAwakn Life Sciences Corp0.56News ReleaseAwakn talks revenue, omits Q2 2022 P&L in NR
2022-09-14 19:04C:AWKNAwakn Life Sciences Corp0.57SEDAR MD & ASEDAR MD & A
2022-09-14 18:56C:AWKNAwakn Life Sciences Corp0.57SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-09-12 12:10C:AWKNAwakn Life Sciences Corp0.57News ReleaseAwakn signs deal to conduct FS with MDMA, Zydis
2022-08-25 10:02C:AWKNAwakn Life Sciences Corp0.60News ReleaseAwakn signs 12-month option for Project Kestrel
2022-08-18 09:47C:AWKNAwakn Life Sciences Corp0.65News ReleaseAwakn signs licensing partnership with Wellbeings
2022-08-15 11:11C:AWKNAwakn Life Sciences Corp0.53News ReleaseAwakn licenses AUD therapy treatment to Revitalist
2022-07-20 09:58C:AWKNAwakn Life Sciences Corp0.70News ReleaseAwakn receives $2.5M of funding for AUD therapy trial
2022-07-15 10:25C:AWKNAwakn Life Sciences Corp0.78News ReleaseAwakn begins beta phase of licensing business
2022-07-05 11:01C:AWKNAwakn Life Sciences Corp0.59News ReleaseAwakn Life receives U.K. funding for AUD therapy
2022-06-14 17:50C:AWKNAwakn Life Sciences Corp0.70News ReleaseAwakn talks momentum, omits Q1 P&L from NR
2022-06-14 17:11C:AWKNAwakn Life Sciences Corp0.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2022-06-14 17:11C:AWKNAwakn Life Sciences Corp0.70SEDAR MD & ASEDAR MD & A
2022-06-07 13:31C:AWKNAwakn Life Sciences Corp1.05News ReleaseAwakn appoints Purcell as special adviser to CEO
2022-06-02 10:17C:AWKNAwakn Life Sciences Corp1.23News ReleaseAwakn begins behavioural study on gambling disorder
2022-05-26 17:14C:AWKNAwakn Life Sciences Corp1.21News ReleaseAwakn files patent application for ketamine treatment
2022-05-19 10:41C:AWKNAwakn Life Sciences Corp1.35News ReleaseAwakn Life Sciences completes ketamine treatment study
2022-05-17 13:18C:AWKNAwakn Life Sciences Corp1.26News ReleaseAwakn Life Sciences appoints Dhandayudham as CMO
2022-04-28 17:56C:AWKNAwakn Life Sciences Corp1.30News ReleaseAwakn talks revenue, omits fiscal 2022 P&L in NR
2022-04-28 16:54C:AWKNAwakn Life Sciences Corp1.30SEDAR Annual Information FormSEDAR Annual Information Form
2022-04-28 16:54C:AWKNAwakn Life Sciences Corp1.30SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2022-04-28 16:54C:AWKNAwakn Life Sciences Corp1.30SEDAR MD & ASEDAR MD & A
2022-04-13 12:01C:AWKNAwakn Life Sciences Corp1.55News ReleaseAwakn Life Sciences talks U.K., Norway clinics
2022-04-06 11:54C:AWKNAwakn Life Sciences Corp1.60News ReleaseAwakn Life completes phase 1 of drug discovery program